Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
PFE

Pfizer

$40.07

0.65 (1.65%)

, GSK

GlaxoSmithKline

$47.07

0.12 (0.26%)

18:54
01/14/20
01/14
18:54
01/14/20
18:54
Periodicals
Breaking Periodicals news story on Pfizer, GlaxoSmithKline »

Pfizer planning IPO of…

PFE

Pfizer

$40.07

0.65 (1.65%)

GSK

GlaxoSmithKline

$47.07

0.12 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 27

    Jan

  • 28

    Jan

  • 10

    Feb

  • 13

    Feb

  • 13

    Feb

PFE

Pfizer

$39.42

-0.08 (-0.20%)

08:31
01/14/20
01/14
08:31
01/14/20
08:31
Hot Stocks
Insilico Medicine enters research collaboration with Pfizer »

Insilico Medicine is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 27

    Jan

  • 28

    Jan

  • 10

    Feb

  • 13

    Feb

  • 13

    Feb

AXSM

Axsome Therapeutics

$88.29

-0.45 (-0.51%)

, PFE

Pfizer

$39.42

-0.08 (-0.20%)

07:04
01/14/20
01/14
07:04
01/14/20
07:04
Recommendations
Axsome Therapeutics, Pfizer analyst commentary at Ladenburg »

Axsome Therapeutics price…

AXSM

Axsome Therapeutics

$88.29

-0.45 (-0.51%)

PFE

Pfizer

$39.42

-0.08 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 27

    Jan

  • 28

    Jan

  • 10

    Feb

  • 13

    Feb

  • 13

    Feb

Monday
ZYME

Zymeworks

$44.89

-1.285 (-2.78%)

, PFE

Pfizer

$39.50

0.62 (1.59%)

07:35
01/13/20
01/13
07:35
01/13/20
07:35
Recommendations
Zymeworks, Pfizer analyst commentary at Guggenheim »

Zymeworks named Best Idea…

ZYME

Zymeworks

$44.89

-1.285 (-2.78%)

PFE

Pfizer

$39.50

0.62 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

  • 27

    Jan

  • 28

    Jan

  • 10

    Feb

  • 13

    Feb

  • 13

    Feb

BIIB

Biogen

$296.56

1.94 (0.66%)

, PFE

Pfizer

$39.50

0.62 (1.59%)

07:32
01/13/20
01/13
07:32
01/13/20
07:32
Hot Stocks
Biogen to acquire novel clinical stage asset PF-05251749 from Pfizer »

Biogen Inc. (BIIB)…

BIIB

Biogen

$296.56

1.94 (0.66%)

PFE

Pfizer

$39.50

0.62 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

  • 27

    Jan

  • 28

    Jan

  • 30

    Jan

  • 10

    Feb

  • 13

    Feb

  • 13

    Feb

AXSM

Axsome Therapeutics

$88.74

1.56 (1.79%)

, PFE

Pfizer

$39.50

0.62 (1.59%)

06:06
01/13/20
01/13
06:06
01/13/20
06:06
Hot Stocks
Axsome Therapeutics enters exclusive U.S license agreement with Pfizer »

Axsome Therapeutics…

AXSM

Axsome Therapeutics

$88.74

1.56 (1.79%)

PFE

Pfizer

$39.50

0.62 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

  • 27

    Jan

  • 28

    Jan

  • 10

    Feb

  • 13

    Feb

  • 13

    Feb

Sunday
ZYME

Zymeworks

$44.89

-1.285 (-2.78%)

, PFE

Pfizer

$39.50

0.62 (1.59%)

15:25
01/12/20
01/12
15:25
01/12/20
15:25
Hot Stocks
Zymeworks announces agreement with Pfizer, initiation of Phase 2 Trial »

Zymeworks (ZYME)…

ZYME

Zymeworks

$44.89

-1.285 (-2.78%)

PFE

Pfizer

$39.50

0.62 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 28

    Jan

  • 10

    Feb

  • 13

    Feb

  • 13

    Feb

Over a week ago
GSK

GlaxoSmithKline

$46.65

0.24 (0.52%)

, PFE

Pfizer

$38.88

-0.17 (-0.44%)

08:19
01/10/20
01/10
08:19
01/10/20
08:19
Hot Stocks
ViiV Healthcare submits regulatory application to EMA for fostemsavir »

ViiV Healthcare, the HIV…

GSK

GlaxoSmithKline

$46.65

0.24 (0.52%)

PFE

Pfizer

$38.88

-0.17 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 28

    Jan

  • 10

    Feb

  • 13

    Feb

  • 13

    Feb

AMRN

Amarin

$19.77

0.32 (1.65%)

, PFE

Pfizer

$39.09

0.04 (0.10%)

10:23
01/09/20
01/09
10:23
01/09/20
10:23
Hot Stocks
Former Pfizer R&D head says no Amarin deal shows Big Pharma avoiding Vascepa »

John LaMattina, the…

AMRN

Amarin

$19.77

0.32 (1.65%)

PFE

Pfizer

$39.09

0.04 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 28

    Jan

  • 10

    Feb

  • 13

    Feb

  • 13

    Feb

PFE

Pfizer

$39.05

0.29 (0.75%)

09:24
01/09/20
01/09
09:24
01/09/20
09:24
Periodicals
Pfizer loses appeal in patent suit over Hospira's Precedex »

An appeals court affirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 28

    Jan

  • 10

    Feb

  • 13

    Feb

  • 13

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.